American Transplant Congress June 12, 2016
American Transplant Congress June 12, 2016 Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in de novo living donor kidney transplant recipients. » Download Full Abstract
All posts by gjohnson@tracttherapeutics.com
International Society for Cellular Therapy
International Society for Cellular Therapy, Miltenyi Biotec Corporate Symposium, May 27, 2015, Las Vegas, NV Ann LeFever, PhD to present “Large Scale GMP Manufacturing of Regulatory T Cells for Tolerance Induction”
TRACT Therapeutics, Inc. in White City News
“A kidney transplant that lasts for life. It’s the ultimate goal. But the drugs that keep a donor organ going also pose the greatest threat. Now a new approach to fighting off rejection. Chicago based TRACT Therapeutics aims to remove the need for organ transplant patients to take immunosuppressive drugs by Continue reading